Personal Genome Diagnostics Inc. (PGDx), headquartered in the United States, is a pioneering leader in the field of precision medicine and genomic testing. Founded in 2013, PGDx has rapidly established itself as a key player in the oncology diagnostics industry, focusing on the development of innovative genomic solutions for cancer patients. The company offers a range of unique products and services, including comprehensive genomic profiling and liquid biopsy tests, which enable clinicians to make informed treatment decisions based on individual tumour characteristics. PGDx's commitment to advancing cancer care is underscored by its notable achievements, including collaborations with leading research institutions and a growing portfolio of intellectual property. With a strong market position, PGDx continues to drive advancements in personalised medicine, helping to transform cancer treatment and improve patient outcomes across major operational regions in the US and beyond.
We don't have data for Personal Genome Diagnostics Inc., but we can show you information about their parent organization instead.
View parent company